172 related articles for article (PubMed ID: 25607436)
1. Rituximab or azathioprine maintenance in ANCA-associated vasculitis.
Chouchana L; Beaune P; Loriot MA
N Engl J Med; 2015 Jan; 372(4):386. PubMed ID: 25607436
[No Abstract] [Full Text] [Related]
2. Rituximab or azathioprine maintenance in ANCA-associated vasculitis.
Vandergheynst F
N Engl J Med; 2015 Jan; 372(4):385-6. PubMed ID: 25607435
[No Abstract] [Full Text] [Related]
3. Rituximab or azathioprine maintenance in ANCA-associated vasculitis.
Hebert LA; Alvarado A; Rovin B
N Engl J Med; 2015 Jan; 372(4):385. PubMed ID: 25607434
[No Abstract] [Full Text] [Related]
4. Rituximab or azathioprine maintenance in ANCA-associated vasculitis.
Pagnoux C; Guillevin L; ;
N Engl J Med; 2015 Jan; 372(4):386-7. PubMed ID: 25607433
[No Abstract] [Full Text] [Related]
5. Extending the indications for rituximab in ANCA-associated vasculitis.
Jayne D
N Engl J Med; 2014 Nov; 371(19):1839-40. PubMed ID: 25372093
[No Abstract] [Full Text] [Related]
6. Clinical trials. Rituximab for maintenance of remission in AAV.
Tanna A; Pusey C
Nat Rev Nephrol; 2015 Mar; 11(3):131-2. PubMed ID: 25599619
[TBL] [Abstract][Full Text] [Related]
7. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.
Guillevin L; Pagnoux C; Karras A; Khouatra C; Aumaître O; Cohen P; Maurier F; Decaux O; Ninet J; Gobert P; Quémeneur T; Blanchard-Delaunay C; Godmer P; Puéchal X; Carron PL; Hatron PY; Limal N; Hamidou M; Ducret M; Daugas E; Papo T; Bonnotte B; Mahr A; Ravaud P; Mouthon L;
N Engl J Med; 2014 Nov; 371(19):1771-80. PubMed ID: 25372085
[TBL] [Abstract][Full Text] [Related]
8. S2. Rituximab for ANCA-associated vasculitis: the UK experience.
Jayne D
Presse Med; 2013 Apr; 42(4 Pt 2):532-4. PubMed ID: 23490639
[No Abstract] [Full Text] [Related]
9. B-cell therapy in antineutrophil cytoplasmic antibody-associated vasculitis.
Kallenberg CG; Hauser T
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i119-22. PubMed ID: 25753806
[TBL] [Abstract][Full Text] [Related]
10. L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?
Hoffman GS
Presse Med; 2013 Apr; 42(4 Pt 2):643-50. PubMed ID: 23474045
[No Abstract] [Full Text] [Related]
11. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
[TBL] [Abstract][Full Text] [Related]
12. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
Nossent JC
N Engl J Med; 2010 Nov; 363(21):2072; author reply 2073-4. PubMed ID: 21083400
[No Abstract] [Full Text] [Related]
13. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
Hebert LA; Ardoin S; Shim RL
N Engl J Med; 2010 Nov; 363(21):2072-3; author reply 2073-4. PubMed ID: 21083399
[No Abstract] [Full Text] [Related]
14. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
Schönermarck U; Rau S; Fischereder M
N Engl J Med; 2010 Nov; 363(21):2072; author reply 2073-4. PubMed ID: 21083401
[No Abstract] [Full Text] [Related]
15. [Rituximab to treat ANCA-associated vasculitis].
Guillevin L; Mahr A
Rev Med Interne; 2011 Oct; 32(10):591-3. PubMed ID: 21872370
[No Abstract] [Full Text] [Related]
16. New horizons for treatment of ANCA-associated vasculitides.
Guillevin L; Mahr A
Rheumatology (Oxford); 2012 Apr; 51(4):583-4. PubMed ID: 21729933
[No Abstract] [Full Text] [Related]
17. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
[TBL] [Abstract][Full Text] [Related]
18. Rituximab for ANCA-associated vasculitides.
Guillevin L
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S118-21. PubMed ID: 24854382
[TBL] [Abstract][Full Text] [Related]
19. Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.
Karassa FB
N Engl J Med; 2010 Nov; 363(21):2073; author reply 2073-4. PubMed ID: 21083398
[No Abstract] [Full Text] [Related]
20. [Maintainance treatment of anti-neutrophil cytoplasm associated antibodies (ANCA)].
Dábague Guzmán J; Pedroza Granados J; Zúñiga Varga J
Reumatol Clin; 2011 Dec; 7 Suppl 3():S37-40. PubMed ID: 22119277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
